Group treatment of auditory hallucinations

Exploratory study of effectiveness TIL WYKES. ANN-MARIE PARR and SABINE LANDAU
Background Cognitive-behavioural therapy has been shown to be effective in reducing psychotic symptoms, but few patients have access to these services.
Group cognitive treatment may provide a less costly service with similar benefits.
Alms To explore the effectiveness of group cognitive-behavioural therapy on insight and symptoms, particularly auditory hallucinations.
Method Twenty-one DSM -IV diagnosed patients with schizophrenia with treatment-resistant, distressing auditory hallucinations were referred to a group programme consisting of six sessions of cognitive treatment following a strict protocol which emphasised individual power and control as well as coping strategies.
Results There were significant changes in all three main outcome measures following treatment; those changes were maintained at follow-up and were greater than changes over the waiting-list period.
Specifically, there were changes in perceived power and distress as well as increases in the number and effectiveness ofthe coping strategies.
Conclusions Group treatment for auditory hallucinations needs further investigation but does look promising and may provide a less costly alternative to individual cognitive treatment.
Declaration of interest None.
Despite high doses of medication a sign&-cant number of people with schizophrenia still experience distressiig auditory hallucinations. These not only affect the quality of their lives but are probably instrumental in maintaining depression and low selfesteem. The efficacy of psychological treatment in addition to pharmacotherapy has been established in a number of randomised resistant auditory hallucinations which were not the result of an organic disorder.
Main outcome measures
Auditory Haffuanations Rating Scak (PSY-RATS; Haddock et al, 1999) . A self-report scale with proven reliability and validity which measures emotional content, physical characteristics and cognitive interpretation.
Expanded Brief Psychiatric Rating Scale (BPRSE; Ventura et al, 1993), completed by an independent clinician who was not blind to treatment status.
Self-Report Insight Scak for Psychosis (IS; Birchwood et al, 1994) . A self-report questionnaire which provides measures of symptom attribution, awareness of illness and acceptance of the need for treatment. This study adopted a waiting-list control design with repeated measures within subjects. However, a few people were only referred when the groups started; these referrals were also included in the study. The efficacy of treatment was evaluated using seven symptom measures and one measure of coping. Participants were allocated to one of three groups through a rolling programme of referrals based on service contact with three community teams. Each
Intervention
Sessions were based on a cognitivebehavi o d approach, followed a semi& format and lasted for an hour. Each session dealt with a particular theme: Week 24 -follow-up session.
Subjects were included in the study if Each session followed a detailed protocol they experienced distressing, medicationcontaining the aims of the session, examples of interventions and model responses for the therapist.
Statistical analysis
For the analysis of the main and ancillary outcomes, unbalanced repeated-measures models assuming an unstructured covariance matrix were employed to impute missing observations (see for example Everitt, 1998) . Models were fitted into the software package BMDP, release 7 (Dixon, 1992) using the method of restricted maximum likelihood. The effect of time was tested using the Wald statistic; when this was sigdicant, specific Wald tests were carried out over three periods: waiting, treatment and follow-up. Finally, if there was evidence of a treatment effect we compared it with the changes over the waiting period as a control condition. Even when it could be argued that the comparisons between the treatment phase and the control phase (waiting time) were supported by a specific hypothesis we decided to adopt the most conservative approach, so all tests were two-tailed.
RESULTS
Patient sample
The participants were representative of those who continue to attend mental health services with resistant psychotic symptoms. All 21 had a diagnosis of schizophrenia according to DSM-TV criteria (American Psychiatric Association, 1994). They had high scores on the BPRS-E with both negative and positive symptoms, and moderate levels of depression on the BPRS-E, which were about the same as estimates obtained from the recent cognitive-behavioural therapy (CBT) study reported by Kuipers et a1 (1997) . They generally were middle-aged (average age 40 years) and had a long duration of illness (mean duration of hearing voices 14 years), and about half were living in psychiatric residences. Threequarters experienced voices daily, these voices mostly having a negative content (95%), and 75% also reported that the voices caused at least a moderate amount of disruption to their lives. All subjects were on stable doses of neuroleptic medications: 48% were prescribed one of the novel antipsychotic medications, the average dose (British National remainder were prescribed standard neuroleptics with an average chlorpromazine dose equivalent of 343.18 (sd. 205).
Thirteen of the 21 people referred to the study completed the course of treatment and some post-treatment assessment, although only erght of these entered the trial during the waiting-list period. This led to considerable differences in the number of observations available for the pairwise comparisons, as shown in Table  1 for the main outcomes.
Drop out
The dropout mechanism was investigated by comparing socio-demographic, clinical or outcome variables at the pre-treatment stage for the group of participants whose PSYRATS totals were missing at posttreatment andlor follow-up stage (n=ll) with the remaining participants for whom scores existed (n=10). There were no si@cant differences between the groups on any of the variables. Figure 1 shows the estimated mean BPRS-E scores; a reduction in score indicates a symptom improvement. The BPRS-E score was affected by the assessment time (Wald test: x2=37.7, d.f.=3, P<0.0001). There was no significant difference over the waiting period (estimated mean difference (e.m.d.)=5.8, 95% confidence interval (CI) -1.9 to 13.5) but scores were si@-cantly reduced over the treatment period (Wald test: $=26.02, d.f.=l, P<0.0001, e.m.d.=7.9, 95% CI 4.9 to 10.9). This reduction was not maintained at follow-up (e.m.d.=2,95% CI -2.8 to 6.8). The control test supported a treatment effect larger than expected from the waiting period 
Main outcomes
Expanded Brief Psychiatric Rating Scok (BPRS-E)
Specific clinical outcomes
The treatment programme was designed to target a number of specific issues relating to voices. These specific targets were measured by individual items or factor scores, except for the coping strategy measure. These data were analysed with paired ttests over each of the three assessment periods. The means and confidence intervals for the mean differences are given in Table 3 . rsSdl-Rcpatlnrbhr-f'JrRlchodr. 
G R O U P T R E A T M E N T O F A U D I T O R Y H A L L U C I N A T I O N S
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There is only one significant change over the waiting period -a decrease in the physical attributes of the voices. There were statistically significant differences in the predicted direction over the treatment period for three measures, and for a further four the confidence intervals were extremely skewed. These data, therefore, indicate a targeted treatment effect. At followup, however, the size of the improvements was reduced and only one (increased coping W e 4 Coping scntq$as used by patienu strategies) achieved significance, although there was a trend for reduced distress severity. The data for these individual items are not as robust as for the total scores, suggesting that treatment effects may be different for each individual.
Ancillary outcomes
The Wald tests did not indicate an effect of assessment time for anxiety (BAI: 2=6.1, reported receiving any benefit. After the and increased effectiveness (percentage effective: baseline (n=ll) 73%, pre-treatment (n=lS) 54%, post-treatment (n=12) 92%, follow-up (n=9) 78%; sign test prepost-treatment P c 0.016, two-tailed).
There were no differences during the waiting period and the change in effectiveness disappeared at follow-up.
Associations with improvement
Multiple stepwise (forward) regression analyses were carried out, with change in each outcome measure over the treatment period as the dependent variable and demographic, clinical and other pre-treatment outcome measures as independent variables. No significant predictors emerged for any of the main outcomes. Biichwood & Chadwick (1997) suggest that there is a relationship between the perceived power of the voices and the effect generated by the voices. Reductions in power should, therefore, have a beneficial effect on distress. There was a significant partial correlation in the predicted direction between the change in perceived power and the post-treatment levels of distress after controlling for pre-treatment levels (partial r=0.63, P=O.04). Although symptom assessments were independent of the treatment they could not be blind, as everyone received treatment.
DISCUSSION
The study described in this paper explored in a group format would add value because the group processes themselves are particularly powerful. The participants were representative of those who attend most psychiatric services regularly. They had medication-resistant symptoms at the levels described in a similar study of individual CBT (Kuipen et al, 1997) . Although people did drop out of the study it was possible to use the data from all 21 people recruited.
Does treatment produce significant effects?
The analyses suggest that the main outcome measures of global symptoms do change over time in the direction predicted. Symptoms changed little over the waiting period, and improved over the treatment phase; this improvement was maintained at followup. Clearly, the study may have benefited from a comparison with a control group that did not receive treatment. However, the waiting-time control is a conservative measure of 'no treatment' as it includes the effects of treatment expectancy. Significant treatment effects relative to control were found for both BPRS and IS, and there was a strong trend in the required direction for PSYRATS. Improvements in the main outcomes could not be explained by changes in specific measures, which leads us to assume that individuals make different adjustments following treatment which are only reflected in the total scores. There were some relationships between the changes over therapy and the changes in key outcome measures. For example, changes in voice powerfulnets did reduce distress, and half the group who completed treatment improved their perceived control over the voices. This is an important result, as people with schizophrenia who feel less control over their voices are more likely to be violent (Cheung et a1, 1997). Although it has been suggested that increasing coping strategies might be beneficial (Lee et al, 1993; Carter et al, 1996) , it was not directly related to the outcome measures in the present study. Rather, it seems that the ability to engage in coping strategies might influence the person's perception of control over their experience and the distress associated with the voices. Unfortunately, many of these interesting possibilities cannot be tested with the current data. Larger subject numbers would allow covariance modelling, which might elucidate them.
Is treatment clinically use!ful?
Participants had experienced treatmentresistant distressing hallucinations for an -average of 14 years. Although many reported that medication had helped, most said that they had never been free of these experiences even when taking adequate doses. All the participants for whom we have complete data expressed a high degree of satisfaction with the group. Talking about the voices with others who had similar experiences was reported as being particularly beneficial, and many patients commented on how easily they were able to communicate within the group. Many patients said they were 'comforted' by the fact that they were not alone in their experiences. Among the most frequently reported benefits were the educational aspects of the therapy, particularly with regard to medication, and the learning of new coping skdh (such as "~0 I I f r 0 n~g the voices and asking them to come back later").
How does group treatment compare with individual CBT?
Group treatment produces reductions in the total BPRS-E score (7.9 points) similar to those achieved in individual treatment studies (e.g. Kuipers et a1, 1997). However, the cost ratio when compared with individual care is 1:14. That is, one person completing individual treatment for 14 completing group treatment. It is, of course, possible that this form of therapy has fewer long-term benefits than individual CBT. The follow-up in this study was very short, and even then there was a fall-off in the treatment effects. Alternatively, group treatment could be considered as a supplement to individual CBT, intre ducing the participants to the processes involved in individual work. It may then help to reduce the duration of individual treatments or even haease the effectiveness of individual CBT. The current exploratory study does, of course, require replicating in a more standard randomised controlled mal, especially as results are promising. Group treatment for hallucinations may be a practical alternative psychological treatment which has less dependence on expert therapist time and which could improve the prognosis of many people with treatment-resistant psychotic symptoms.
